Dial 040-44885000 Or Press Here to Book an Appointment

Dr. Rithvik Golla

Consultant Gastroenterologist, Hepatologist & Interventional Endoscopist

OP Timings:

MondayTuesdayWednesdayThursdayFridaySaturdaySunday
09:00am - 05:00pm09:00am - 05:00pm09:00am - 05:00pm09:00am - 05:00pm09:00am - 05:00pm09:00am - 05:00pmNot Available

Qualifications:

  • 2020-2023: D.M. (Gastroenterology) - All India Institute of Medical Sciences, New Delhi
  • 2016-2019: M.D. (General Medicine) - Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh
  • 2010-2016: M.B.B.S. - Osmania Medical College, Hyderabad


Fellowship:

Advanced Endoscopy and Endoscopic Ultrasound (FIAE) – 6 months (Under Dr. Malay Sharma, Aryavart Hospital, Meerut)


Expertise:

  • Diagnostic and Therapeutic Upper GI Endoscopy
  • Diagnostic and Therapeutic Sigmoidoscopy and Colonoscopy
  • Endoscopic Retrograde Cholangiopancreatography (ERCP)
  • Diagnostic and Therapeutic Endoscopic Ultrasound (EUS)
  • Esophageal and Anorectal Manometry


Area of Interest:

  • Endoscopic Ultrasound (Diagnostic and Therapeutic)
  • Inflammatory Bowel Disease
  • Hepatology


Publications:

1) Golla R, Vuyyuru S, Kante B, Kumar P, Thomas DM, Makharia G, Kedia S, Ahuja V.

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study. Clin Gastroenterol Hepatol. 2023 Mar;21(3):789-796.e1. 

doi: 10.1016/j.cgh.2022.10.015.

2) Golla R, Vuyyuru SK, Kante B, Kedia S, Ahuja V. Disorders of gut-brain interaction in post-acute COVID-19 syndrome. Postgrad Med J. 2023 Jul 21;99(1174):834-843. 
doi: 10.1136/pmj-2022-141749. 

3) Golla R, Kumar, S., Dhibhar, D. P., Bhalla, A., & Sharma, N. (2022). 0.9% saline V/S Ringer’s lactate for fluid resuscitation in adult sepsis patients in emergency medical services: An open-label randomized controlled trial. Hong Kong Journal of Emergency Medicine, 29(5), 271–280.

4) Golla R, Mukherjee A, Gone RK, Singh H, Pannu AK, Suri V, Bhalla A. Acute intermittent porphyria and anti-tuberculosis therapy. QJM. 2020 Mar 1;113(3):207-208. doi: 10.1093/qjmed/hcz289. PMID: 31693148.

5) Gupta A, Vuyyuru SK, Kante B, Kumar P, Farooqui M, Ranjan MK, Singh N, Mundhra SK, Madan D, Golla R, Singh N, Makharia G, Kedia S, Ahuja V. "Prevalence, Predictors, and Impact of Hepatic Steatosis in Patients with Ulcerative Colitis: A Prospective Observational Cohort Study". J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101293. doi: 10.1016/j.jceh.2023.10.004.

6) Ranjan MK, Kumar P, Kumar Vuyyuru S, Kante B, Mundhra SK, Golla R, Virmani S, Sharma R, Sahni P, Das P, Kalaivani M, Upadhyay AD, Makharia G, Kedia S, Ahuja V. Thiopurines have sustained long-term effectiveness in patients with inflammatory bowel disease which is independent of disease duration at initiation: A propensity score matched analysis. J Crohn’s Colitis. 2023 Aug 16:jjad135. doi: 10.1093/ecco-jcc/jjad135.

7) Kumar P, Vuyyuru SK, Das P, Kante B, Ranjan MK, Thomas DM, Mundhra S, Sahu P, Venigalla PM, Jain S, Goyal S, Golla R, Virmani S, Singh MK, Sachdeva K, Sharma R, Dash NR, Makharia G, Kedia S, Ahuja V. Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring. Intest Res. 2023 Oct;21(4):460-470. doi: 10.5217/ir.2022.00128.

8) Kante B, Vuyyuru SK, Gupta R, Dwivedi T, Kumar P, Mundhra S, Golla R, Virmani S, Verma M, Makharia G, Ahuja V, Kedia S. High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India. Indian J Gastroenterol. 2023 Feb;42(1):70-78. doi: 10.1007/s12664-022-01310-y.

9) Kumar P, Vuyyuru SK, Kante B, Kedia S, Sahu P, Ranjan MK, Mundhra S, Golla R, Kumar M, Virmani S, Gupta A, Yadav N, Makharia G, Ahuja V. Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis. Indian J Gastroenterol. 2022 Oct;41(5):446-455. doi: 10.1007/s12664-022-01252-5.

10) Swaroop S, Arora U, Biswas S, Vaishnav M, Pathak P, Agarwal A, Golla R, Thakur B, Coshic P, Andriyas V, Gupta K, Elhence A, Nayak B, Kumar R, Shalimar. Therapeutic plasma-exchange improves short-term, but not long-term, outcomes in patients with acute-on-chronic liver failure: A propensity score-matched analysis. J Clin Apher. 2023 Aug;38(4):376-389. doi: 10.1002/jca.22033.

11) Shalimar, Sheikh SS, Biswas S, Vaishnav M, Pathak P, Pachisia AV, Narang H, Prasad   S, Mehta S, Dhooria A, Swaroop S, Golla R, Agarwal A, Kumar R, Acharya SK. Incidence and Predictors of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. J Clin Exp Hepatol. 2023 Jan-Feb;13(1):37-47. doi: 10.1016/j.jceh.2022.09.007.

12) Ranjan MK, Vuyyuru SK, Kante B, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V. Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease. Int J Colorectal Dis. 2022 Aug;37(8):1817-1826. doi: 10.1007/s00384-022-04216-5.

13) Kante B, Vuyyuru SK, Gupta R, Dwivedi T, Kumar P, Mundhra S, Golla R, Virmani S, Verma M, Makharia G, Ahuja V, Kedia S. P720 Similar risk of infection with SARS-CoV-2 in immunocompromised and immunocompetent patients with inflammatory bowel disease and healthy controls. J Crohns Colitis. 2022 Jan 21;16(Suppl 1):i614–5. doi: 10.1093/ecco-jcc/jjab232.841.

14) Ranjan MK, Kante B, Vuyyuru SK, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V. Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India. J Gastroenterol Hepatol. 2022 Aug;37(8):1544-1553. doi: 10.1111/jgh.15880.

15) Kumar P, Vuyyuru SK, Kante B, Sahu P, Goyal S, Madhu D, Jain S, Ranjan MK, Mundhra S, Golla R, Singh M, Virmani S, Gupta A, Yadav N, Kalaivani M, Sharma R, Das P, Makharia G, Kedia S, Ahuja V. Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region. Aliment Pharmacol Ther. 2022 Jun;55(11):1431-1440. doi: 10.1111/apt.16839.

16) Pannu AK, Golla R, Kumari S, Suri V, Gupta P, Kumar R. Aetiology of pyrexia of unknown origin in north India. Trop Doct. 2021 Jan;51(1):34-40. doi: 10.1177/0049475520947907.

17) Kumar S, Golla R, Bhalla A, Sharma N, Varma S. 0.9% Saline v/s Ringer's Lactate for fl uid resuscitation in adult sepsis patients in emergency medical services: An open label Randomized Controlled trial. J Assoc Physicians India. 2020 Jan;68(1):87.

18) Pannu AK, Golla R. Spontaneous expulsion of a pulmonary hydatid cyst through bronchial rupture. Trop Doct. 2018 Oct;48(4):350-352. doi: 10.1177/0049475518789550.

19) Pannu AK, Golla R (2017) Response to Vitamin B12 deficiency may coexist with endocrine causes of hyperpigmentation. QJM: Int J Med 771

Awards and Recognition:

  • “DR. POLISETTI HRISHIKESH S.P.M GOLD MEDAL” awarded for securing highest marks in S.P.M in 2014.
  • Institute Gold Medal for securing highest marks in third year MBBS in 2014.
  • “DR. MADHUSUDHAN. T. GUPTA GEN. MEDICINE GOLD MEDAL” awarded for securing highest marks in General Medicine in 2015.
  • Secured 1st price in poster presentation at 5th Annual Congress of the Indian Motility and Functional Diseases Association (IMFDA) in 2022.
  • Invited as Speaker to deliver a talk on “Long-term Gastrointestinal Sequelae Following COVID-19” at The 32nd Annual Meeting of the Korean College of Helicobacter and Upper Gastrointestinal Research to be held in Seoul, South Korea in March 2024.
 
Memberships:
1) Indian Society of Gastroenterology (ISG)
2) Colitis & Crohn’s Foundation (India)
3) American Society of Gastrointestinal Endoscopy (ASGE)

Patient videos loading...
Doctor videos loading...
News & Events loading...
Doctors talk loading...

BOOK AN APPOINTMENT

FIND A DOCTOR

Footer Loading...